Metabolic syndrome.
By H. Minuk. Journal of Insurance Medicine, 2005
8,289 citations recorded by the source corpus.
View Paper: https://www.semanticscholar.org/paper/92e38646c003d23ab3cb2c5e50beace7a7a7d02b
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Lisa Sullivan
- E. Kassi
- Jingjing Wang
- Peter W. F. Wilson
- Ralph B. D’Agostino
- Liping Zhao
- A. Lonardo
- P. Angulo
Citations in the corpus
- Triglycerides and the Risk of Coronary Heart Disease: 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies (2007, unknown): “Current cigarette smoker, n (%) 962 (39) 1266 (32) 0.”
- Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice (2014, background): “Humans are facing a devastating epidemic of metabolic syndrome (MS), symptoms of which include obesity, hyperglycemia, insulin resistance, hyperlipidemia and hypertension (Eckel et al., 2005).”
- Adverse Childhood Experiences and Adult Risk Factors for Age-Related Disease (2009, unknown): “Instead, we focused on intermediate risk factors such as depression, inflammation, and the clustering of metabolic risk markers, which are known to predict agerelated diseases.(11,18,44) Although we were unable to measure disease outcomes, we believe that the investigation of relevant intermediate p”
- Adipose tissue plasticity in health and disease (2022, background): “Indeed, obesity, especially central (abdominal) obesity, is associated with several metabolic pathologies, including hyperglycemia, low HDL cholesterol, hypertriglyceridemia, and hypertension, which together are often called ‘‘metabolic syndrome’’ (Lanktree and Hegele, 2017).”
- Metabolic flexibility in health and disease (2017, unknown): “Substantial evidence implicates elevated FFA levels [from inappropriate lipolysis] as a significant etiological factor for insulin resistance and type 2 diabetes (Eckel et al., 2005; Frayn and Coppack, 1992; Frayn et al., 1996; Randle et al., 1963; Savage et al., 2007).”
- Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. (2016, background): “Cu–Zn superoxide dismutase (SOD) is downregulated along with other antioxidant system in body such as catalase and glutathione peroxidase (GPx) [21].”
- [Obesity and metabolic syndrome in children and adolescents]. (2013, background): “De aquí que se ha propuesto el nombre de síndrome metabólico para unir alteraciones metabólicas y clínicas que se ha demostrado que pueden ser indicadores de riesgo aumentado de esas enfermedades (3-9).”
- Impact of Dietary Polyphenols on Carbohydrate Metabolism (2010, background): “disorder of energy homeostasis encompassing obesity, hyperglycemia, impaired glucose tolerance, hypertension and dyslipidemia [9].”
- Bioactive protein hydrolysates in the functional food ingredient industry: Overcoming current challenges (2017, background): “The term metabolic syndrome describes a combination of medical disorders including obesity, hypertension and diabetes, all of which increase the risk of developing cardiovascular disease.((20)) Some of these factors can be treated and/or controlled by the inhibition”
- Multimorbidity patterns: a systematic review. (2014, background): “The first group of patterns was composed by a core of diseases (ie, hyperlipidemia, hypertension, heart disease, diabetes, and obesity) with similarities to the metabolic syndrome widely described in the scientific literature [41].”